The global sodium phenylbutyrate market has been growing significantly over the past decade. Sodium phenylbutyrate is an odorless white powder that is primarily utilized as a nitrogen-binding drug for the management of various urea cycle disorders. It works by blocking the accumulation of ammonia in the bloodstream, which could be harmful or even fatal if left untreated. Sodium phenylbutyrate is prescribed for the treatment of urea cycle disorders like CPS1 deficiency, OTC deficiency, and some other rare defects. The growing diagnosis rate of these inherited metabolic disorders has significantly contributed to the rising demand for sodium phenylbutyrate among healthcare professionals over the years.

The Global sodium phenylbutyrate market is estimated to be valued at US$ 2.22 Bn in 2024 and is expected to exhibit a CAGR of 18% over the forecast period 2024 To 2031.

Key Takeaways

Key players operating in the sodium phenylbutyrate market are Halliburton Co., Hifi Engineering Inc., Silixa Ltd., Schlumberger Limited, Banweaver, Omnisens SA, Future Fibre Technologies Ltd., Baker Hughes, Inc., Qintiq Group PLC, and Fotech Solutions Ltd. The increasing recognition of urea cycle disorders and favorable government funding towards rare disease treatment have propelled the demand for sodium phenylbutyrate across major markets. With effective diagnosis and long-term management, survival rates for UCD patients have improved significantly over the past decade. This has further contributed to the rising consumption of sodium phenylbutyrate globally. Manufacturers are investing heavily in expanding their global footprint, especially in emerging Asian countries where metabolic disorders diagnosis is still developing.

Growing demand in market:

The rising incidence of urea cycle disorders due to improved diagnosis and heightened disease awareness has boosted the consumption of Sodium Phenylbutyrate Market Trends for management of hyperammonemia. Furthermore, the lack of effective alternative treatments for UCDs has further consolidated the position of sodium phenylbutyrate as the primary therapeutic option for controlling ammonia levels in blood.

Global expansion of market:

Leading manufacturers in the sodium phenylbutyrate market have successfully expanded their presence across key geographical regions. For example, Horizon Therapeutics has established strict distribution networks across the United States, Europe, and several other emerging markets. Other players like American Regent are also expanding their global footprint with new licensing agreements. This increasing geographical outreach is expected to meet the rising need for sodium phenylbutyrate in both developed and developing regions.

Get More Insights on, Sodium Phenylbutyrate Market

Get More Insights on, Sodium Phenylbutyrate Market